All Photos(1)
About This Item
Linear Formula:
FC6H3(NO2)NH2
CAS Number:
Molecular Weight:
156.11
Beilstein:
2210197
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22
Recommended Products
Assay
97%
mp
90-94 °C (lit.)
functional group
fluoro
nitro
SMILES string
Nc1ccc(F)cc1[N+]([O-])=O
InChI
1S/C6H5FN2O2/c7-4-1-2-5(8)6(3-4)9(10)11/h1-3H,8H2
InChI key
PUGDHSSOXPHLPT-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
General description
4-Fluoro-2-nitroaniline forms complexes with cobalt(II), nickel(II) and copper(II).
Application
4-Fluoro-2-nitroaniline was used as starting reagent in the synthesis of 4-fluoro-N-ethyl-2-nitroaniline and N-(4-fluoro-2-nitrophenyl)-β-alanine.
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
192.2 °F - closed cup
Flash Point(C)
89 °C - closed cup
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Thomas Hussenether et al.
Bioorganic & medicinal chemistry, 12(10), 2625-2637 (2004-04-28)
Novel 4-arylpiperazin-1-yl-substituted 2,3-dihydro-1H-1,4- and 1H-1,5-benzodiazepines and their aza-analogues were synthesized as debenzoclozapine derivatives for evaluation as potential D4-ligands. While Ki values of some of the title compounds came within the range of clozapine, they showed an impressively greater selectivity over
Complexes of copper (II), nickel (II) and cobalt (II) with 2-fluoro, 5-nitroaniline and 4-fluoro, 2-nitroaniline.
DeVoto G, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 38(7), 725-728 (1982)
S Singh et al.
The Journal of pharmacology and experimental therapeutics, 296(2), 600-611 (2001-02-13)
The diseases of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are characterized by mucus-congested airways. Agents that stimulate the secretion of Cl- are anticipated to facilitate mucociliary clearance and thus be of benefit in the treatment of CF
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service